Truist Financial Corp Curis Inc Transaction History

Truist Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$2.31 - $5.13 $449,006 - $997,143	-194,375 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $44,500 - $80,900	-10,000 Reduced 4.89%	194,375 $925,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $91,635 - $200,121	12,300 Added 6.4%	204,375 $1.65 Million
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $875,778 - $1.28 Million	99,747 Added 108.04%	192,075 $2.17 Million
Q4 2020 Feb 18, 2021	BUY	$1.08 - $8.2 $52,200 - $396,338	48,334 Added 109.86%	92,328 $756,000
Q4 2019 Feb 14, 2020	BUY	$1.36 - $2.44 $59,831 - $107,345	43,994 New	43,994 $75,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.